CYTOKINETICS INCORPOR

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 4 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis

31 3 2023 07:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics Releases Inaugural Corporate Responsibility Report

27 3 2023 07:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics to Participate in Upcoming Investor Conferences

06 3 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session

04 3 2023 10:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 3 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Reports Fourth Quarter 2022 Financial Results

01 3 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Receives Complete Response Letter From FDA for New Drug Application for Omecamtiv Mecarbil

28 2 2023 17:31:51 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Three Upcoming Presentations at the American College of Cardiology 72nd Annual Scientific Session

24 2 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

22 2 2023 07:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics to Announce Fourth Quarter Results on March 1, 2023

15 2 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 2 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program

30 1 2023 07:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 1 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

03 1 2023 16:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil

13 12 2022 17:45:52 提供 Nasdaq GlobeNewswire

Cytokinetics Stock Trading Halted Today

13 12 2022 07:02:16 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

09 12 2022 08:59:34 提供 Nasdaq GlobeNewswire

Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND

08 12 2022 07:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136

07 12 2022 07:30:00 提供 Nasdaq GlobeNewswire